DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $514,000 | -56.5% | 25,509 | -19.5% | 0.00% | -66.7% |
| Q2 2021 | $1,182,000 | +63.9% | 31,680 | +12.4% | 0.00% | +50.0% |
| Q1 2021 | $721,000 | +25.0% | 28,183 | +7.6% | 0.00% | 0.0% |
| Q4 2020 | $577,000 | +60.7% | 26,194 | +31.2% | 0.00% | 0.0% |
| Q3 2020 | $359,000 | -31.5% | 19,962 | -3.3% | 0.00% | -33.3% |
| Q2 2020 | $524,000 | +127.8% | 20,641 | +64.5% | 0.00% | +50.0% |
| Q1 2020 | $230,000 | -52.2% | 12,547 | -42.5% | 0.00% | 0.0% |
| Q4 2019 | $481,000 | +37.4% | 21,817 | -10.6% | 0.00% | 0.0% |
| Q3 2019 | $350,000 | -13.4% | 24,406 | -4.9% | 0.00% | 0.0% |
| Q2 2019 | $404,000 | +1.5% | 25,673 | -5.5% | 0.00% | 0.0% |
| Q1 2019 | $398,000 | +38.2% | 27,156 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $288,000 | +274.0% | 26,927 | +105.7% | 0.00% | +100.0% |
| Q3 2016 | $77,000 | +67.4% | 13,089 | -15.2% | 0.00% | 0.0% |
| Q2 2016 | $46,000 | -49.5% | 15,428 | -9.2% | 0.00% | 0.0% |
| Q1 2016 | $91,000 | -59.2% | 16,983 | -9.5% | 0.00% | -66.7% |
| Q4 2015 | $223,000 | – | 18,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |